Jialiang Du

机构：National Medical Products Administration, National Institutes for Food and Drug Control · ORCID：0000-0003-1495-5521

发表论文 69 篇 · 总被引 445 次 · h-index 13

代表论文

• Human rotavirus strains circulating among children in the capital of China (2018–2022)_ predominance of G9P[8] and emergence ofG8P[8] (2023 · Heliyon · 被引 16)
• Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity (2024 · Analytica Chimica Acta · 被引 12)
• In-depth characterization of a cysteine-linked ADC disitamab vedotin by multiple LC-MS analysis methods and cutting-edge imaged capillary isoelectric focusing coupled with native mass spectrometry (2024 · Journal of Chromatography A · 被引 11)
• A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates (2024 · Journal of Chromatography B · 被引 10)
• Application of microfluidic modulation spectroscopy for simultaneous structural and thermal stability analysis of commercial mAbs under varying formulation conditions (2025 · Analytical Methods · 被引 6)
• Next‐Generation HER‐2 Tumor‐Targeted Delivery of the STING Agonist Immune‐Stimulating Antibody Conjugate (ISAC) Improves Anticancer Efficacy and Induces Immunological Memory (2025 · MedComm · 被引 4)